Back to search

France· FR:62719472

SIALANAR 320 microgrammes/ml, solution buvable

A glycopyrronium product containing bromure de glycopyrronium, registered in France by PROVECA PHARMA LIMITED (IRLANDE), on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC D11AA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSIALANAR 320 microgrammes/ml, solutio…ATCD11AA01REGISTER NO.FR:62719472PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Glycopyrronium is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Glycopyrronium · ATC D11AA01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
BROMURE DE GLYCOPYRRONIUM
Manufacturer
PROVECA PHARMA LIMITED (IRLANDE)
Country
France (FR)
ATC code
D11AA01
ATC class
Glycopyrronium
Defined daily dose
8.8 mg, T
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930146019
    1 flacon en verre ambré de 250 mL avec fermeture de sécurité enfant avec seringue pour administration orale polyéthylène basse densité (PEBD) de 8 mL et adaptateur
    EUR 422.19
  • cip13
    3400930278062
    1 flacon en verre ambré de 60 mL avec fermeture de sécurité enfant avec seringue pour administration orale polyéthylène basse densité (PEBD) de 8 mL et adaptateur
    EUR 101.91

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for glycopyrronium.

Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glycopyrronium · interactions on record

108 records

  • 107 moderate
  • 1 minor

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9436385-7f4f-4da2-9f10-49dcc536cdf4
GET /v1/drugs/f9436385-7f4f-4da2-9f10-49dcc536cdf4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62719472",
  "date_amm": "2016-09-15",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/16/1135",
  "substance": "BROMURE DE GLYCOPYRRONIUM",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about glycopyrronium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.